| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.37 | 7e-15 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.36 | 9e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.32 | 1e-10 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.28 | 5e-10 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-10 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.29 | 5e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.51 | 6e-09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-09 |